Writing in JAMA, four former governmental officials warn that the Trump administration’s involvement in delaying the approval ...

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...

As for Nuvaxovid, this standalone Novavax Covid-19 vaccine received its FDA approval in May, a regulatory decision that covers its use in those age 65 and older.

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...

Novavax NVAX announced encouraging results from an initial cohort of a late-stage study evaluating its experimental COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates.

Nuvaxovid lasts six months under the same conditions. “The Novavax vaccine is much less demanding,” Fei Wen, a chemical engineer at the University of Michigan, told The Daily Beast.

Novavax, which makes the Nuvaxovid vaccine used to treat Covid-19, posted huge sales gains for the past three years during the height of the pandemic. But the company is now facing serious ...

Nuvaxovid is supplied in a single-dose prefilled syringe containing 0.5mL suspension for intramuscular injection; it should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F).

Novavax's combo and standalone flu vaccines showed strong immune responses and good safety in a Phase 3 trial of adults 65 and older.

NUVAXOVID’s approval is also a major milestone for the U.S. population and the healthcare industry, as it is the first and only full FDA approval for a non-mRNA, protein-based COVID-19 vaccine.